Domzalski David 4
4 · VYNE Therapeutics Inc. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Tax Payment
Common Stock
2024-12-31$3.35/sh−24,536$82,196→ 476,061 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.